Smelling trouble in the brain {#cesec10}
=============================

Despite the direct neuronal path between the nose and the brain\'s [olfactory bulb](https://doi.org/10.1126/sciimmunol.abb1817){#interrefs10}, airborne diseases rarely cause fatal encephalitis. Findings from a study in mice suggest that viruses can reach the olfactory bulb but a frontline immune reaction prevents any damage or further spread. Using a fluorescent vesicular stomatitis virus, researchers showed how scavenger immune cells in the brain called microglia acquire viral material from neurons and present themselves for destruction to T cells. Such kamikaze, neuron-sparing immune activity, though, is not needed in neurons outside of the brain, which, unlike those in the brain, can be replaced, possibly explaining why severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a temporary loss of smell.

You rang? {#cesec20}
=========

Respiratory syncytial virus ([RSV](https://doi.org/10.1038/s41586-020-2369-7){#interrefs20}) uses a receptor called nucleolin to enter cells, but it was hitherto unknown how the virus signals to nucleolin to come to the cell surface. Findings from experiments in human bronchial epithelial cells show that RSV binds to an upstream receptor called IGF1R and a gene protein called PKC-zeta, using the two to signal nucleolin from the nucleus. Inhibition of PKC-zeta reduced viral replication and pathology in RSV-infected mice. Better understanding of this mechanism might lead to treatments against the virus, which kills up to 200 000 mostly babies and young children a year.

All in this together {#cesec30}
====================

Findings from a genetic study of [SARS-CoV-2-like](http://dx.doi.org/10.1126/sciadv.abb9153){#interrefs30} viruses in bats and pangolins show near-identical genetic sequences around the viral receptor binding motifs (RBMs), a similarity that might have led to species spillover and the evolution of the virus that causes disease in people. The analysis of 43 complete genome sequences from three strains of coronavirus suggest that similar constraints within animal hosts led to strong purifying selection, and the researchers suggested that close contact with wild animals in wet markets increased the risk of spillover and genetic reshuffling. In support of their theory was the finding that SARS-CoV-2\'s entire RBM was introduced through recombination with coronaviruses from pangolins.

Tet(X7) me {#cesec40}
==========

First the bad news. US researchers have found bacterial genes conferring resistance to tetracyclines to be widespread in samples from soil, human stool, animal faeces, and latrines in the USA and Peru. By searching functional metagenomic libraries for samples associated with tetracycline resistance, they discovered 69 new so-called destructase genes with the potential to lead to enzymatic destruction of tetracyclines. One of which, [Tet(X7)](http://dx.doi.org/10.1038/s42003-020-0966-5){#interrefs40}, was human-associated and conferred resistance against all 11 tetracyclines tested when spliced into otherwise susceptible *Escherichia coli.* The good news is that the same team had been working on a compound to counter destructase activity that increased sensitivity to tetracyclines by two to four times in Tet(X7)-containing *Pseudomonas aeruginosa* isolates.

Jumping on flu {#cesec50}
==============

Findings from a modelling study suggest that the scale-up of the use of new influenza drug baloxavir could avert millions of infections compared with use of oseltamivir. Baloxavir inhibits viral mRNA synthesis, whereas oseltamivir inhibits release of virus progeny, meaning the newer drug can prevent onward transmission quicker and more completely. The findings suggest that if [baloxavir](http://dx.doi.org/10.1038/s41467-020-16585-y){#interrefs50} had been given to only 30% of people infected during the 2017--18 season within 48h of symptom onset, around 22 million global infections and more than 6000 death could have been averted. The findings suggest additional benefits of fast-acting treatments in future candidate drugs against SARS-CoV-2.

Maths vs COVID {#cesec60}
==============

Mathematicians have identified a sensitivity to perturbations in the main protease of [SARS-CoV-2](https://doi.org/10.1063/5.0008834){#interrefs60} that could be a promising target for future treatments. The team used protein residue network analysis-- mathematical models to describe proteins, taking into the account the fact that proteins are dynamic and are affected by their surroundings. Despite a similarity in amino acid sequence with the SARS-CoV protease (only 12 of 306 residues don\'t match), they found SARS-CoV-2 to be 1900% more sensitive to perturbations, such as water within the intracellular environment. Next steps are to use the approach to screen for potent destabilising inhibitors of the protease.

Out with a bang {#cesec70}
===============

US researchers have announced the preliminary findings that suggest the discovery of a compound that holds promise against Gram-negative drug-resistant bacteria. [SCH-79797](http://dx.doi.org/10.1016/j.cell.2020.05.005){#interrefs70} has a dual mode of action against the cell membrane and intracellular folate. The team was unable to detect resistance in either Gram-negative or Gram-positive bacteria, including totally drug resistant *Neisseria gonorrhoeae,* so established the mechanisms of resistance using quantitative imaging, proteomic, genetic, metabolomic, and cell-based assays. The team developed a derivative, Irresistin-16, that is less toxic against animal cells than its parent compound, and they used it to successful clear *N gonorrhoeae* infections in mice.
